Literature DB >> 31030848

Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018.

L Huber1, S Giguère1, N D Cohen2, N M Slovis3, L Berghaus1, M Greiter3, K A Hart1.   

Abstract

Rhodococcus equi causes severe pneumonia in foals and is most often recognized in people as an opportunistic pathogen. Longitudinal studies examining antimicrobial-resistant R. equi from environmental samples are lacking. We hypothesized that antimicrobial-resistant R. equi would be detectable in the ground (pasture soil or stall bedding) and air at breeding farms with previous documentation of foals infected with resistant isolates, and that concentrations of resistant isolates would increase over time during the foaling season. In this prospective cohort study, ground and air samples were collected from stalls and paddocks in January, March, May and July of 2018 at 10 horse-breeding farms with history of foal pneumonia attributed to macrolide- or Rifampicin-resistant R. equi. Environmental samples were cultured in the presence and absence of macrolides and Rifampicin to select for resistant organisms. Data were analyzed with linear mixed-effects and Hurdle models. Concentrations of total R. equi in bedding or air of stalls were significantly (P < 0.05) higher in January than other months. The proportion of resistant R. equi in soil samples from paddocks was significantly (P < 0.05) higher than stall bedding during all months. For each month, air samples from paddocks had a significantly (P < 0.05) higher proportion of resistant isolates than those from stalls. Fifty-five percent of resistant soil isolates and 34% of resistant air isolates were considered virulent by identification of the vapA gene. Concentrations of resistant R. equi isolates did not increase over time during the foaling season. Antimicrobial-resistant R. equi can persist in the environment at farms with a history of pneumonia caused by resistant R. equi infections, and exposure to resistant isolates in paddocks and stalls appears stable during the foaling season. Resistant isolates in the environment not only pose a risk for disease but also can serve as a repository for dissemination of resistance genes.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Foal pneumonia; Macrolide- and rifampicin-resistance; Rhodococcus equi

Mesh:

Substances:

Year:  2019        PMID: 31030848     DOI: 10.1016/j.vetmic.2019.04.008

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  5 in total

Review 1.  Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Laura Huber; Steeve Giguère; Kelsey A Hart; Roy D Berghaus; Susan Sanchez; Noah D Cohen
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-14       Impact factor: 11.056

2.  Host-directed therapy in foals can enhance functional innate immunity and reduce severity of Rhodococcus equi pneumonia.

Authors:  Angela I Bordin; Noah D Cohen; Steve Giguère; Jocelyne M Bray; Londa J Berghaus; Brenton Scott; Rena Johnson; Magnus Hook
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

3.  Characterisation of and risk factors for extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX-M-1.

Authors:  Katariina Thomson; Katarina Eskola; Marjut Eklund; Kristiina Suominen; Merita Määttä; Jouni Junnila; Suvi Nykäsenoja; Kati Niinistö; Thomas Grönthal; Merja Rantala
Journal:  Acta Vet Scand       Date:  2022-02-09       Impact factor: 1.695

4.  A Novel Screening Strategy Reveals ROS-Generating Antimicrobials That Act Synergistically against the Intracellular Veterinary Pathogen Rhodococcus equi.

Authors:  Álvaro Mourenza; José A Gil; Luís M Mateos; Michal Letek
Journal:  Antioxidants (Basel)       Date:  2020-01-28

5.  A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.

Authors:  S Álvarez-Narváez; L J Berghaus; E R A Morris; J M Willingham-Lane; N M Slovis; S Giguere; N D Cohen
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.